http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1106742-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b6fc801b5bfe5304ffa40d938db6e09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D227-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D227-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
filingDate 1965-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1968-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1106742-A
titleOfInvention New piperidine derivatives and the homologues thereof and process for their production
abstract Compounds of the formula <FORM:1106742/C2/1> wherein X represents an oxo group or the groups <FORM:1106742/C2/2> wherein R1 is an alkyl radical containing at most 7 carbon atoms and R2 is a divalent hydrocarbon radical containing 2 to 10 carbon atoms; Y represents the oxo group or the group <FORM:1106742/C2/3> wherein R4 is an alkylene radical which is preferably saturated and contains at most 5 carbon atoms; R represents hydrogen or a methyl radical; and n represents 0, 1 or 2 and their salts with inorganic and organic acids and preparation thereof by condensing a compound of the formula <FORM:1106742/C2/4> wherein X, R and n have the above significance with a suitable reactive ester derived from a compound of the formula <FORM:1106742/C2/5> wherein Y has the above meaning, in an organic solvent in the presence of an acid binding agent with optional subsequent hydrolysis to an oxo group of one or both of the groups X and Y when these symbols represent ketal groups and, if desired, with further selective re-introduction of different ketal groups. Substituted 4-piperidone derivatives of the second general formula above, wherein X represents <FORM:1106742/C2/6> and R2 has the aforementioned significance, are prepared by condensing 4,4-dihydroxypiperidine hydrochloride with a suitable dihydric alcohol in the presence of p-toluenesulphonic acid. Pharmaceutical compositions suitable for oral, rectal or parenteral administration, comprising as active ingredient at least one compound of the first general formula above or a pharmaceutically acceptable organic or inorganic acid addition salt in association with at least one pharmaceutical carrier, act as calmatives, psychoregulators or sedatives. The preparation of 1-[41-(p-fluorophenyl)-41-oxo - 11 - butyl] - 4,4 - ethylenedioxy-piperidine, [4 - (p-fluorophenyl) - 41,41 - ethylenedioxy - 11-butyl] - 4,4 - ethylenedioxy - piperidine, 1 - [41-(p-fluorophenyl) - 41 - oxobutyl] - 4,4 - ethylenedioxy-piperidine, 1 - [(41 - p - fluorophenyl) - 41 - oxo - 11 - butyl] - 4 - piperidone, 1 - [41 -p-fluorophenyl - 41 - oxobutyl] - 4,4 - dihydroxy-piperidine and 1 - [(41 - p - fluorophenyl) - 41-oxo -11 - butyl] - 4,4 - diethoxy - piperidine is given and numerous other compounds corresponding to the first general formula above are described. 1 - (p-Fluorophenyl) - 1,1 - ethylenedioxy - 4-chlorobutane and 2 - (p - fluorophenyl) - 2 - (3-chlorobutyl) - 4 - methyl - m - dioxan are obtained by ketalization of p-fluoro-g -chlorobutyrophenone with the appropriate dihydric alcohol in the presence of p-toluenesulphonic acid. 4,4-Dimethoxypiperidine is prepared by reacting 4,4-dihydroxypiperidine hydrochloride with methyl alcohol in the presence of p-toluenesulphonic acid. p-Fluoro-g -chlorobutyrophenone is prepared by a Friedel-Crafts reaction between fluorobenzene and g -chlorobutyric acid.
priorityDate 1964-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154391602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447954481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432516003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID557469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416149893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11636836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422525924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 42.